Sleep Medication, Edluar, gets swedish backed European approval

Friday, 15 June 2012
Edluar has received registration approval in Europe via the decentralized procedure with Sweden acting as Reference Member State.
According to a press release, Edluar is used for treating sleep disorders and contains zolpidem, a well-documented active ingredient. National registration processes will now follow in each country. The first launches are expected early next year.

Edluar was launched in the US market in 2009 and the launch in Canada (brand Sublinox) started early 2012. Edluar/Sublinox uses a unique, patented sublingual tablet formulation for fast and effective absorption.
“With this approval, we cover the key markets. We will now continue the registration process on other interesting markets”, said Anders Lönner, CEO of Meda AB in the press release.
By Scancomark.se Team

What do you think about this article or us? Please leave a comment. Thank you!